Stay updated on SBRT ± Nivolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SBRT ± Nivolumab in NSCLC Clinical Trial page.

Latest updates to the SBRT ± Nivolumab in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe revision tag on the page was updated from v3.5.3 to v3.5.4, indicating a new version of the page. It does not modify the study content or how the page is presented.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s software/document revision indicator was updated from v3.5.2 to v3.5.3, reflecting a backend/version change rather than a modification to the study record content.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded page revision details for v3.5.2 with April 2026 dates and removed references to v3.5.0.SummaryDifference0.3%

- Check58 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3. This update appears to modify internal versioning information and does not change displayed content.SummaryDifference0.1%

- Check66 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3. There are no observable changes to study details or core content.SummaryDifference0.1%

- Check94 days agoChange DetectedAdded Revision: v3.4.2 and removed the older notices, including the lapse in government funding message and Revision: v3.4.1.SummaryDifference0.4%

Stay in the know with updates to SBRT ± Nivolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT ± Nivolumab in NSCLC Clinical Trial page.